伊卡里因通过激活cAMP/PKA/CREB通路,促进NF1基因淘汰的细胞模型中的骨质分化
Meng Chen1,2,3, Lianhua Lu1, Dong Cheng1
1Shandong Center for Disease Control and Prevention, Jinan 250014, China.
Molecules (Basel, Switzerland)
|July 14, 2023
概括
伊卡林通过激活cAMP/PKA/CREB通路,促进神经纤维素瘤类型1 (NF1) 的骨生长. 这项研究引入了针对NF1相关骨缺陷的新疗法策略.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 1型神经纤维素瘤 (NF1) 是一种遗传性疾病,在50%的患者中影响骨发育.
- 在NF1中骨问题的确切原因尚不清楚,治疗选择有限.
研究的目的:
- 为了研究NF1骨病背后的分子机制.
- 探索伊卡林对NF1相关骨缺陷的潜在治疗作用.
主要方法:
- 创建了一个骨质细胞模型与NF1基因淘汰.
- 给NF1细胞模型注射伊卡林,并分析其对cAMP/PKA/CREB通路的影响.
- 使用PKA抑制剂 (H89) 来确认途径的参与.
主要成果:
- NF1基因淘汰会降低cAMP水平和骨质分化.
- 伊卡里因增加了细胞内cAMP水平,激活了cAMP/PKA/CREB通路.
- 伊卡林在NF1细胞模型中显著促进了骨质细胞分化,这种效应被H89.9所削弱.
结论:
- 伊卡林通过cAMP/PKA/CREB通路在NF1细胞模型中有效促进骨质分化.
- 这项研究为NF1骨病提供了一种新的治疗方法.
- 这些发现为未来的药物开发和针对NF1骨并发症的临床策略铺平了道路.
相关概念视频
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
Induced Pluripotent Stem Cells
4.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.2K
MAPK Signaling Cascades
5.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K


